Tauriga Sciences, Inc. engages in the development, distribution, and licensing of proprietary products. It also engages in evaluation of potential acquisition opportunities and equity investments. The firm operates through the Tauri-gum & Pharma segments. The Tauri-gum segment consists of retail, wholesale, and e-commerce product sales of Tauri-Gum, Tauri-Gummies, and other cannabigerol/cannabidiol products. The Pharma segment is involved in research and development. The company was founded on April 8, 2001 and is headquartered in Wappingers Falls, NY.